<DOC>
	<DOCNO>NCT00033592</DOCNO>
	<brief_summary>RATIONALE : Use nicotine inhaler and/or bupropion may effective help people stop smoke prevent start smoking . It yet know whether nicotine inhaler bupropion effective alone combine stop smoking . PURPOSE : Randomized phase III trial compare effectiveness nicotine inhaler bupropion alone nicotine inhaler combine bupropion help people stop smoke prevent start smoking .</brief_summary>
	<brief_title>Comparison Nicotine Inhaler and/or Bupropion Helping People Stop Smoking Prevent Recurrence Smoking</brief_title>
	<detailed_description>OBJECTIVES : I . Compare effectiveness nicotine inhaler v bupropion v nicotine inhaler plus bupropion smoking cessation prevention relapse participant currently smoke . II . Compare reduction rate relapse smoke initial abstinence participant treat long term regimen . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord gender , cigarettes smoked per day time screen ( 10-39 v 40 ) , total length smoking year ( less 5 vs 5-9 v 10 ) . Participants randomize one three treatment arm . Arm I : Participants receive 6-16 nicotine inhaler cartridge per day . Arm II : Participants receive oral bupropion 1-2 time daily . Arm III : Participants receive 6-16 nicotine inhaler cartridge per day oral bupropion 1-2 time daily . In arm , treatment continue 12 week . After 12 week , participant randomize second time base whether continue smoke smoke-free . Participants randomize arm I continue smoke randomize one two treatment arm . Arm IV : Participants receive oral bupropion 1-2 time daily 12 week Arm V : Participants receive oral placebo 1-2 time daily 12 week . Participants randomize arm II continue smoke randomize one two treatment arm . Arm VI : Participants receive 6-16 nicotine inhaler cartridge per day 12 week . Arm VII : Participants receive 6-16 placebo inhaler cartridge per day 12 week . Participants randomize arm III continue smoke receive therapy . Participants randomize arm I smoke-free randomized one two treatment arm . Arm VIII : Participants receive 6-16 nicotine inhaler cartridge per day 40 week . Arm IX : Participants receive 6-16 placebo inhaler cartridge per day 40 week . Participants randomize arm II smoke-free randomize one two treatment arm . Arm X : Participants receive oral bupropion 1-2 time daily 40 week . Arm XI : Participants receive oral placebo 1-2 time daily 40 week . Participants randomize arm III smoke-free randomize one four treatment arm . Arm XII : Participants receive 6-16 nicotine inhaler cartridge per day oral placebo 1-2 time daily 40 week . Arm XIII : Participants receive 6-16 placebo inhaler cartridge per day oral bupropion 1-2 time daily 40 week . Arm XIV : Participants receive 6-16 nicotine inhaler cartridge per day oral bupropion 1-2 time daily 40 week . Arm XV : Participants receive 6-16 placebo inhaler cartridge per day oral placebo 1-2 time daily 40 week . All participant follow every month 6 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Currently smoke least 10 cigarette per day Smoked regularly past year Motivated use study medication More 30 day since prior use tobacco product cigarette ( e.g. , smokeless tobacco , pipe , cigar , snuff ) No active chemical dependence drug nicotine ( e.g. , alcohol , marijuana , cocaine , heroin , illicit drug ) within past year PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No unstable angina , myocardial infarction , cardiac arrhythmia within past 3 month Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception least 3 month prior study Good health medical history No history seizure disorder No epilepsy No prior serious head trauma predispose factor seizure ( e.g. , alcohol withdrawal , febrile seizure childhood , brain tumor , cerebrovascular accident , family history idiopathic seizure disorder ) No know hypersensitivity allergy nicotine , menthol , bupropion No prior concurrent diagnosis bulimia anorexia nervosa No member household currently enrol study No bipolar disorder , psychosis , schizophrenia PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : More 30 day since prior systemic steroid Radiotherapy : Not specify Surgery : Not specify Other : More 30 day since prior behavioral pharmacologic smoke cessation program ( e.g. , behavioral therapy , nicotine replacement therapy , clonidine , bupropion , nortriptyline , doxepin ) More 30 day since prior investigational drug More 30 day since prior antipsychotic antidepressant More 30 day since prior theophylline More 30 day since prior monoamine oxidase inhibitor More 30 day since prior medication contain bupropion No concurrent antiepileptic medication No concurrent medication know low seizure threshold No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
</DOC>